Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals
The Journal of Dermatology · 2024
DOI: 10.1111/1346-8138.17187 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Yu-Jen Chiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Asian People, Gene Expression Profiling. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Veterans General Hospital, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Melanoma predominantly occurs in White individuals, which is associated with factors such as exposure to UV radiation and skin pigmentation. Despite its low incidence, melanoma is the primary cause of skin cancer–related death in Asia, typically in areas with low sun exposure. In our previous whole‐exome sequencing study, we identified mutational signature 12 as the most prevalent variant in Asian patients, differing from the common UV‐associated mutational signature 7 observed in White individuals. We also observed major differences between acral melanoma (AM) and nonacral melanoma (NAM) in terms of signatures 7, 21, and 22. Notably, few studies have investigated the genomic differences between AM and NAM in Asian individuals. Therefore, in this study, we conducted transcriptomic sequencing to examine the disparities in RNA expression between AM and NAM. Ribosomal RNA depletion was performed to enhance the detection of functionally relevant coding and noncoding transcripts. Ingenuity pathway analysis revealed significant differences in gene expression and regulatory pathways between AM and NAM. The results also indicate that the genes involved in cell cycle signaling or immune modulation and programmed cell death protein 1/programmed cell death 1 ligand 1 signaling were differentially expressed in NAM and AM. In addition, high CDK4 expression and cell cycle variability were observed in AM, with high immunogenicity in NAM. Overall, these findings provide further insights into the pathogenesis of melanoma and serve as a reference for future research on this major malignant disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Surgery, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.
- Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Surgery, School of Medicine, National Defense Medical Center, Taipei, Taiwan.
Förderung
- Taipei Veterans General Hospital
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Chiu, Y. J., Li, C. Y., Wang, T. H., Ma, H., & Chou, T. Y. (2024). Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17187
Vancouver
Chiu YJ, Li CY, Wang TH, Ma H, Chou TY. Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17187
BibTeX
@article{Chiu2024,
author = {Chiu, Yu-Jen and Li, Cheng-Yuan and Wang, Tien-Hsiang and Ma, Hsu and Chou, Teh-Ying},
title = {Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals},
journal = {The Journal of Dermatology},
year = {2024},
doi = {10.1111/1346-8138.17187}
}
EUVIMED